Haemodynamic effects of eprosartan and valsartan in hypertensive patients during isometric and mental stress

被引:16
作者
Arosio, E
De Marchi, S
Prior, M
Rigoni, A
Lechi, A
机构
[1] Univ Verona, Ctr Osped Clin, Div Riabilitaz Cardiovasc, I-37067 Verona, Italy
[2] Univ Verona, Chair Internal Med, I-37067 Verona, Italy
关键词
eprosartan; valsartan; resistance; microcirculation; handgrip; mental stress;
D O I
10.1097/01.hjh.0000182526.74934.1b
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective To assess the effects of eprosartan and valsartan on the haemodynamics of forearm circulation in hypertensives undergoing isometric and mental stress. Design and methods Thirty-six patients with essential stable hypertension underwent haemodynamic evaluations on the left arm: humeral flux and calibre by means of colour Doppler ultrasound, microcirculatory flux on the third finger of left hand by means of laser Doppler flowmetry, blood pressure and heart rate monitor. District resistance was calculated as the ratio between mean arterial pressure and blood flow, and microcirculatory conductance was calculated as the ratio between flux and the mean pressure. The evaluations were performed at rest, during handgrip and during mental stress. Patients were randomized to receive eprosartan (600 mg) or valsartan (1160 mg); tests were repeated after 15 days of therapy. Results Both treatments reduced blood pressure (P < 0.05) and peripheral resistance during tests. Eprosartan obtained a greater reduction in resistance during handgrip than valsartan. Laser Doppler flowmetry showed a significant decrease of flux only with mental stress. Laser Doppler flowmetry showed a reduction in conductance during both tests - this reduction was smaller with eprosartan during handgrip. None of the molecules affected the conductance during mental stress. While both were able to reduce microcirculatory decrease in conductance; in particular, eprosartan controlled this drop during handgrip better than valsartan. Conclusions Angiotensin 11 receptor type 1 inhibition exerts protective effects during adrenergic and noradrenergic stress in hypertensives. Eprosartan is more efficacious than valsartan in controlling noradrenergic effects. J Hypertens 23:1923-1927 (c) 2005 Lippincott Williams & Wilkins.
引用
收藏
页码:1923 / 1927
页数:5
相关论文
共 21 条
[1]  
Balt JC, 2002, J HYPERTENS, V20, pS3
[2]   Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan [J].
Balt, JC ;
Mathy, MJ ;
Pfaffendorf, M ;
van Zwieten, PA .
JOURNAL OF HYPERTENSION, 2001, 19 (12) :2241-2250
[3]   Angiotensin II receptor antagonists [J].
Burnier, M ;
Brunner, HR .
LANCET, 2000, 355 (9204) :637-645
[4]   EFFECTS OF ISOMETRIC-EXERCISE ON BLOOD-CELL ADRENOCEPTORS IN ESSENTIAL-HYPERTENSION [J].
GRAAFSMA, SJ ;
VANTITS, LJ ;
VANHEIJST, P ;
REYENGA, J ;
DEMIRANDA, JFR ;
THIEN, T .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 14 (04) :598-602
[5]   DISPARATE HEMODYNAMIC AND SYMPATHOADRENERGIC RESPONSES TO ISOMETRIC AND MENTAL STRESS IN ESSENTIAL-HYPERTENSION [J].
GROSSMAN, E ;
OREN, S ;
GARAVAGLIA, GE ;
SCHMIEDER, R ;
MESSERLI, FH .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (01) :42-44
[6]   CARDIAC ACCELERATION IN MAN ELICITED BY A MUSCLE-HEART REFLEX [J].
HOLLANDER, AP ;
BOUMAN, LN .
JOURNAL OF APPLIED PHYSIOLOGY, 1975, 38 (02) :272-278
[7]   The effects of mental stress and the cold pressure test on flow-mediated vasodilation [J].
Lind, L ;
Johansson, K ;
Hall, J .
BLOOD PRESSURE, 2002, 11 (01) :22-27
[8]   CUTANEOUS VASCULAR-RESPONSES EVOKED IN THE HAND BY THE COLD PRESSOR TEST AND BY MENTAL ARITHMETIC [J].
MARRIOTT, I ;
MARSHALL, JM ;
JOHNS, EJ .
CLINICAL SCIENCE, 1990, 79 (01) :43-50
[9]   Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan valsartan or irbesartan: Relationship to differences in prejunctional angiotensin II receptor blockade [J].
Ohlstein, EH ;
Brooks, DP ;
Feuerstein, GZ ;
Ruffolo, RR .
PHARMACOLOGY, 1997, 55 (05) :244-251
[10]   The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension [J].
Oparil, S ;
Dyke, S ;
Harris, F ;
Kief, J ;
James, D ;
Hester, A ;
Fitzsimmons, S .
CLINICAL THERAPEUTICS, 1996, 18 (05) :797-810